Claire Brooks

MSc Medical Statistics

Pharmacovigilance Manager

Previously: Portfolio Lead, Radiotherapy & Imaging Trials, Patient and Public Involvement Coordinator

Recent publications

andomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio

Mulholland PJ. et al, (2023), Journal of Clinical Oncology, 41

phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.

Brown NF. et al, (2020), BMC Cancer, 20

Cytosponge™ for post-chemoradiation surveillance of oesophageal cancer: a feasibility study.

Levy S. et al, (2019), Ann Oncol, 30 Suppl 4

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.

Jankowski JAZ. et al, (2018), Lancet, 392, 400 - 408

Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: efficacy and safety in the phase III randomized factorial AspECT Trial

Jankowski JJ. et al, (2018), American Society of Clinical Oncology Annual Meeting (ASCO 2018)

Sarin Exposures in A Cohort of British Military Participants in Human Experimental Research at Porton Down 1945-1987.

Keegan TJ. et al, (2017), Ann Work Expo Health, 62, 17 - 27

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer

Virdee P. et al, (2017), 19th World Congress on Gastrointestinal Cancer

SPARC: A Phase I trial of pre-operative, margin intensive, stereotactic body radiation therapy (SBRT) for previously untreated borderline resectable pancreatic cancer

Odondi LET. et al, (2016)

pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring - supporting patients in their homes.

Weaver A. et al, (2014), Support Care Cancer, 22, 2677 - 2685

Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.

Nicum S. et al, (2013), JOURNAL OF CLINICAL ONCOLOGY, 31

Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study.

Carpenter LM. et al, (2009), BMJ (Clinical research ed.), 338

Mortality in british military participants in human experimental research into chemical warfare agents at Porton Down: Cohort study

Venables KM. et al, (2009), BMJ (Online), 338

Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study.

Venables KM. et al, (2009), BMJ, 338

Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study.

Carpenter LM. et al, (2009), BMJ, 338

Mortality of British military participants in human experimental research into chemical warfare agents at Porton Down

Venables KM. et al, (2009), BMJ: British Medical Journal, 338, 655 - 655

Exposures recorded for participants in the UK Chemical Warfare Agent Human Research Programme, 1941-1989.

Keegan TJ. et al, (2009), Ann Occup Hyg, 53, 83 - 97

Cancer morbidity in british military veterans included in chemical warfare agent experiments at porton down: Cohort study

Carpenter LM. et al, (2009), BMJ (Online), 338

Reconstructing exposures from the UK chemical warfare agent human research programme.

Keegan T. et al, (2007), Ann Occup Hyg, 51, 441 - 450

Symptoms, ill-health and quality of life in a support group of Porton Down veterans.

Allender S. et al, (2006), Occup Med (Lond), 56, 329 - 337

Symptoms, ill-health and quality of life in a support group of Porton Down veterans

Allender S. et al, (2006), Occupational Medicine, 56, 329 - 337

More publications

Cookies on this website

Contact information

Claire Brooks

Recent publications